Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Sebastiani

Showing results (121-130 of 210) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|October 26, 2019
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patientsGiada Sebastiani, Sahar Saeed, Bertrand Lebouche, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|August 8, 2024
Between-Visit Reproducibility of Shear Wave Viscoelastography in Volunteers and Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseLadan Yazdani, Sathiyamoorthy Selladurai, Iman Rafati, et al.
Nature Reviews. Gastroenterology & Hepatology|October 5, 2023
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver diseaseGong Feng, Luca Valenti, Vincent Wai-Sun Wong, et al.
Clinics and Research in Hepatology and Gastroenterology|June 18, 2025
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antiviralsMohamed Shengir, Wesal Elgretli, Felice Cinque, et al.
Journal of Hepatology|February 15, 2003
Non HFE-related haemochromatosis: exclusion of the 1q21 zinc-iron regulated transporter-like (ZIRTL) gene in juvenile haemochromatosisGiada Sebastiani, Daniel F Wallace, Maria Lioumi, et al.
Journal of Hepatology|May 22, 2017
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosisThomas Pembroke, Marc Deschenes, Bertrand Lebouché, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
The British Journal of Radiology|October 13, 2025
Harnessing Intrinsic Cardiac Motion vs. External Mechanical Vibrations: A Comparison of MRI Cine-Tagging and MR Elastography for Liver Fibrosis AssessmentThierry L Lefebvre, Anton Volniansky, Léonie Petitclerc, et al.
European Radiology|September 3, 2020
Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver diseaseThierry Lefebvre, Mélanie Hébert, Laurent Bilodeau, et al.
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Pageof 21

Showing results (121-130 of 210) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|October 26, 2019
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patientsGiada Sebastiani, Sahar Saeed, Bertrand Lebouche, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|August 8, 2024
Between-Visit Reproducibility of Shear Wave Viscoelastography in Volunteers and Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseLadan Yazdani, Sathiyamoorthy Selladurai, Iman Rafati, et al.
Nature Reviews. Gastroenterology & Hepatology|October 5, 2023
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver diseaseGong Feng, Luca Valenti, Vincent Wai-Sun Wong, et al.
Clinics and Research in Hepatology and Gastroenterology|June 18, 2025
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antiviralsMohamed Shengir, Wesal Elgretli, Felice Cinque, et al.
Journal of Hepatology|February 15, 2003
Non HFE-related haemochromatosis: exclusion of the 1q21 zinc-iron regulated transporter-like (ZIRTL) gene in juvenile haemochromatosisGiada Sebastiani, Daniel F Wallace, Maria Lioumi, et al.
Journal of Hepatology|May 22, 2017
Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosisThomas Pembroke, Marc Deschenes, Bertrand Lebouché, et al.
The Journal of Infectious Diseases|April 7, 2020
Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus InfectionThomas Krahn, Myriam Martel, Ruth Sapir-Pichhadze, et al.
The British Journal of Radiology|October 13, 2025
Harnessing Intrinsic Cardiac Motion vs. External Mechanical Vibrations: A Comparison of MRI Cine-Tagging and MR Elastography for Liver Fibrosis AssessmentThierry L Lefebvre, Anton Volniansky, Léonie Petitclerc, et al.
European Radiology|September 3, 2020
Intravoxel incoherent motion diffusion-weighted MRI for the characterization of inflammation in chronic liver diseaseThierry Lefebvre, Mélanie Hébert, Laurent Bilodeau, et al.
Canadian Liver Journal|August 22, 2022
The 8<sup>th</sup> Canadian Symposium on Hepatitis C virus: "Improving diagnosis and linkage to care"Sophie E Cousineau, Aysegul Erman, Lewis Liu, et al.
Pageof 21